These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20471258)

  • 1. Synthesis and evaluation of azabicyclo[3.2.1]octane derivatives as potent mixed vasopressin antagonists.
    Crombie AL; Antrilli TM; Campbell BA; Crandall DL; Failli AA; He Y; Kern JC; Moore WJ; Nogle LM; Trybulski EJ
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3742-5. PubMed ID: 20471258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of novel opioid ligands with an azabicyclo[2.2.2]octane skeleton and their pharmacologies.
    Watanabe Y; Kitazawa S; Fujii H; Nemoto T; Hirayama S; Nagase H
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2689-92. PubMed ID: 22445285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bridged bicyclic vasopressin receptor antagonists with V(2)-selective or dual V(1a)/V(2) activity.
    Dyatkin AB; Hoekstra WJ; Hlasta DJ; Andrade-Gordon P; de Garavilla L; Demarest KT; Gunnet JW; Hageman W; Look R; Maryanoff BE
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3081-4. PubMed ID: 12372506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A facile synthesis of a polyhydroxylated 2-azabicyclo[3.2.1]octane.
    Reed DD; Bergmeier SC
    J Org Chem; 2007 Feb; 72(3):1024-6. PubMed ID: 17253828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of bicyclo[3.3.0] octane derivatives as dipeptidyl peptidase 4 inhibitors for the treatment of type 2 diabetes.
    Cho TP; Gang LZ; Long YF; Yang W; Qian W; Lei Z; Jing LJ; Ying F; Ke YP; Ying L; Jun F
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3521-5. PubMed ID: 20488704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2,3-disubstituted 6-azabicyclo[3.2.1]octanes as novel dopamine transporter inhibitors.
    Quirante J; Vila X; Bonjoch J; Kozikowski AP; Johnson KM
    Bioorg Med Chem; 2004 Mar; 12(6):1383-91. PubMed ID: 15018911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of new n-substituted cyclic imides with expected anxiolytic activity. XXI. Derivatives of 1-acetyldibenzo-[e.h]-bicyclo[2.2.2]-octane-2,3-dicarboximide.
    Kossakowski J; Szczepek W; Pakosińska-Parys M
    Acta Pol Pharm; 2002; 59(6):418-23. PubMed ID: 12669762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and activity of a potent, specific azabicyclo[3.3.0]-octane-based DPP II inhibitor.
    Danilova O; Li B; Szardenings AK; Huber BT; Rosenblum JS
    Bioorg Med Chem Lett; 2007 Jan; 17(2):507-10. PubMed ID: 17055271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Azabicyclo (2.2.2)octane analogues of the prodine analgetics.
    Clark CR; Holbrook JM; Borne RF
    J Med Chem; 1976 Jun; 19(6):852-4. PubMed ID: 950659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and dopamine transporter binding affinities of 3alpha-benzyl-8-(diarylmethoxyethyl)-8-azabicyclo[3.2.1]octanes.
    Bradley AL; Izenwasser S; Wade D; Klein-Stevens C; Zhu N; Trudell ML
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2387-90. PubMed ID: 12161139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azabicycloalkanes as analgetics. V. 4-Phenyl-2-azabicyclo[2,2,2]octanes.
    Takeda M; Kawamori M; Inoue H; Noguchi K; Nurimoto S
    Chem Pharm Bull (Tokyo); 1977 Apr; 25(4):775-83. PubMed ID: 880720
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and analgetic activity of some 5-aryl-2azabicyclo[3.2.1]octanes.
    Ong HH; Anderson VB; Wilker JC
    J Med Chem; 1978 Aug; 21(8):758-63. PubMed ID: 691001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective synthesis of a novel 2-aza-7-oxabicyclo[3.3.0]octane as neurokinin-1 receptor antagonist.
    Shishido Y; Ito F; Morita H; Ikunaka M
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6887-90. PubMed ID: 17967540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The identification of pyrimidine-diazabicyclo[3.3.0]octane derivatives as 5-HT2C receptor agonists.
    Huck BR; Llamas L; Robarge MJ; Dent TC; Song J; Hodnick WF; Crumrine C; Stricker-Krongrad A; Harrington J; Brunden KR; Bennani YL
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2891-4. PubMed ID: 16546379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activity of 2-carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes.
    Meltzer PC; McPhee M; Madras BK
    Bioorg Med Chem Lett; 2003 Nov; 13(22):4133-7. PubMed ID: 14592523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and pharmacology of site specific cocaine abuse treatment agents: 8-substituted isotropane (3-azabicyclo[3.2.1]octane) dopamine uptake inhibitors.
    Kim DI; Schweri MM; Deutsch HM
    J Med Chem; 2003 Apr; 46(8):1456-64. PubMed ID: 12672245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-((1-Phenyl-1H-1,2,3-triazol-4-yl)methyl)-2-azabicyclo[3.2.1]octan-3-one derivatives: Simplification and modification of aconitine scaffold for the discovery of novel anticancer agents.
    Zhang Y; Zhang TJ; Li XY; Liang JW; Tu S; Xu HL; Xue WH; Qian XH; Zhang ZH; Zhang X; Meng FH
    Eur J Med Chem; 2021 Jan; 210():112988. PubMed ID: 33189438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in vitro muscarinic activities of a series of 3-(pyrazol-3-yl)-1-azabicyclo[2.2.2]octanes.
    Plate R; Plaum MJ; van der Hulst RG; de Boer T
    Bioorg Med Chem; 2000 Feb; 8(2):449-54. PubMed ID: 10722168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and structure-activity relationship of novel opioid κ receptor selective agonists: α-iminoamide derivatives with an azabicyclo[2.2.2]octene skeleton.
    Watanabe Y; Kitazawa S; Fujii H; Nemoto T; Hirayama S; Iwai T; Gouda H; Hirono S; Nagasea H
    Bioorg Med Chem Lett; 2014 Nov; 24(21):4980-3. PubMed ID: 25283554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthesis of derivatives of 2,4-bis(arylmethino)-8-butyl-8- azabicyclo[3.2.1]octan-3-one].
    Gutkowska B; Baranowski A; Herold F
    Acta Pol Pharm; 1989; 46(3):212-8. PubMed ID: 2618767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.